INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • December 10th, 2003 • Neorx Corp • In vitro & in vivo diagnostic substances • New York
This Agreement is being entered into pursuant to the Preferred Stock and Warrant Purchase Agreement, dated as of the date hereof, by and among the Company and the Purchasers (the “Purchase Agreement”).
ContractWarrant Purchase Agreement • December 10th, 2003 • Neorx Corp • In vitro & in vivo diagnostic substances • New York
THIS WARRANT AND THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED, SOLD, ASSIGNED OR TRANSFERRED, IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT REGISTRATION UNDER SAID ACT IS NOT REQUIRED.
PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT by and among NeoRx Corporation, as Issuer and Seller and BayStar Capital II, L.P. and the other parties named herein, as Purchasers with respect to Seller’s Series B Convertible Preferred Stock and...Preferred Stock and Warrant Purchase Agreement • December 10th, 2003 • Neorx Corp • In vitro & in vivo diagnostic substances • New York
PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (the “Agreement”) dated as of December 3, 2003, by and among NeoRx Corporation, a Washington corporation (the “Seller”), and BayStar Capital II, L.P. and each of the other persons listed on Schedule 1 hereto (each is individually referred to as a “Purchaser” and collectively, the “Purchasers”).
